Elicio Therapeutics, Inc.
ELTX
$2.18
-$0.17-7.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.19% | -5.48% | 44.89% | 46.48% | -46.09% |
| Total Depreciation and Amortization | 0.71% | 3.96% | -6.23% | -2.41% | -4.10% |
| Total Amortization of Deferred Charges | -- | 94.29% | 189.33% | -- | -- |
| Total Other Non-Cash Items | -192.09% | 63.75% | -185.44% | -38.80% | 151.47% |
| Change in Net Operating Assets | 458.12% | -473.73% | -60.95% | -337.17% | -127.55% |
| Cash from Operations | 8.77% | -15.08% | 22.27% | -52.41% | -0.25% |
| Capital Expenditure | -- | -- | 64.44% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 64.44% | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 484.93% | -21.69% | 2,042.29% | -17.31% | 838.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.78% | -- | -- | -- | -- |
| Cash from Financing | 38.37% | -22.28% | 2,042.29% | -68.88% | 3,675.95% |
| Foreign Exchange rate Adjustments | -105.41% | -83.87% | -455.56% | 8.33% | 280.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.94% | -1,605.42% | 76.03% | -106.27% | 135.15% |